Long Beach, CALIFORNIA4 Active Studies

Pulmonary Hypertension Clinical Trials in Long Beach, CALIFORNIA

Find 4 actively recruiting pulmonary hypertension clinical trials in Long Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,370
Enrolling

Recruiting Pulmonary Hypertension Studies in Long Beach

RecruitingLong Beach, CALIFORNIANCT06628908

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

1,100 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingLong Beach, CALIFORNIANCT05947851

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypothese...

720 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingLong Beach, CALIFORNIANCT06229210

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder....

500 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingLong Beach, CALIFORNIANCT04747236

Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...

50 participants
University of Virginia
View Study Details

About Pulmonary Hypertension Clinical Trials in Long Beach

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 4 pulmonary hypertension clinical trials recruiting participants in Long Beach, CALIFORNIA. These studies are seeking a combined 2,370 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, Merck Sharp & Dohme LLC, Intra-Cellular Therapies, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Long Beach — FAQ

Are there pulmonary hypertension clinical trials in Long Beach?

Yes, there are 4 pulmonary hypertension clinical trials currently recruiting in Long Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Long Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.

Are clinical trials in Long Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 4 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated March 2, 2026 from ClinicalTrials.gov